Science

Join BenevolentAI's CEO, Joanna Shields, at the Morgan Stanley Putting the Tech in Biotech Conference

Join our CFO, Nick Keher, at the Goldman Sachs Annual Global Healthcare Conference

The FDA has converted its emergency approval of baricitinib to a full approval, underscoring the strength of BenevolentAI’s AI-derived hypothesis.

Join our SVP of Informatics and Data, Mark Davies, at the LSX World Congress for a panel on how AI, machine learning & big data are disrupting the drug discovery & development landscape for faster and more accurate lead identification.

Join BenevolentAI’s Board Director, Jackie Hunter, at ELRIG Research & Innovation 2022.

Join BenevolentAI’s SVP Precision Medicine at the SMi AI in Drug Discovery Conference 2022 for a talk on AI-driven target identification and our collaboration with AstraZeneca.